Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights from the SELECT-ACS Trial

Barbara E. Stähli, Catherine Gebhard, Valërie Duchatelle, Daniel Cournoyer, Thibaut Petroni, Jean Francois Tanguay, Stephen Robb, Jessica Mann, Marie Claude Guertin, R. Scott Wright, Philippe L. L'Allier, Jean Claude Tardif

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights from the SELECT-ACS Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences